NEW ORLEANS, Sept. 19, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 25, 2017 to file lead plaintiff applications in a securities class action lawsuit against Zebra Technologies Corporation (Nasdaq:ZBRA), if they purchased the Company’s shares between March 17, 2015 and May 9, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Zebra Technologies investors should visit us at https://www.claimsfiler.com/cases/view-zebra-technologies-corporation-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Zebra Technologies and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 10, 2016, Zebra announced that its Q1 2016 financial results were “below . . . expectations, with lower sales and earnings reflecting the continuation of a cautious enterprise spending environment.” However, that same day, Zebra revealed that problems had been identified in its internal controls in 2015 that had impacted its ability to accurately forecast its pretax income and deferred taxes.
On this news, the price of Zebra’s shares plummeted more than $11 per share.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Italy Fines Apple €98.6 Million Over App Store Dominance
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 



